Stem Cell Transplants Better Than New Therapies at Delaying Myeloma Progression, Analysis Finds – Myeloma Research News
Myeloma Research News |
Stem Cell Transplants Better Than New Therapies at Delaying Myeloma Progression, Analysis Finds
Myeloma Research News In their evaluation, the primary outcome was progression-free survival (PFS), while secondary outcomes included overall survival, complete response, and treatment-related mortality. Results showed that patients who underwent HDT/ASCT had a 27% higher … |
